By Amy Norton HealthDay Reporter THURSDAY, July 21, 2022 (HealthDay News) — Adding the drug Keytruda to standard chemotherapy can extend the lives of some women with an aggressive form of breast cancer, a new study finds. The study involved women with advanced triple-negative breast cancer, a hard-to-treat form of the disease. Keytruda (pembrolizumab) is … Read more
July 8, 2022 – Yolonda Ross went all-in when she learned that the single mom she plays in Showtime’s acclaimed series The Chi has breast cancer. In season four, episode seven, Ross, who plays Jada, shaved her long hair on camera, bringing to life the very real struggles her character – and actual breast cancer … Read more
By Cara MurezHealthDay Reporter TUESDAY, Dec. 7, 2021 (HealthDay News) — A condition called lymphedema is a well-known side effect of breast cancer treatment that can lead to swelling in the arms and legs. New research suggests that Black women experience are at more than three times the risk of this painful issue compared to … Read more
Digital mammography with tomo synthesis is the advanced breast X-ray diagnostic tool used by breast surgeons to detect early breast cancer By Dr. Rucha Kaushik, Pandemic has affected each one of us at some or other way. It’s been more than one and half years that we all are struggling and coping with the situation … Read more
A lot of progress has been made in the fight against breast cancer, but much work remains. Here’s what the experts say needs to happen next. Source link
By Amy Norton HealthDay Reporter WEDNESDAY, Sept. 22, 2021 (HealthDay News) — Younger women who undergo radiation for cancer in the left breast have a heightened risk of heart disease years later, a new study finds. Among women who received radiation therapy for left-sided breast cancer, 10.5% developed coronary artery disease over the next 27 … Read more
By Denise Mann HealthDay Reporter MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1). … Read more
Alan Mozes HealthDay Reporter TUESDAY, May 4, 2021 (HealthDay News) — A first-of-its-kind study suggests that slow-growing breast cancers can be treated with a highly targeted tumor-freezing technique, eliminating the need for invasive surgery. Testing to date suggests that the technique is effective among women over 60 diagnosed with relatively low-risk breast cancer. “Cryoablation is … Read more
By Cara Murez HealthDay Reporter TUESDAY, May 4, 2021 (HealthDay News) — As the COVID-19 pandemic unfolded, breast cancer experts realized space in operating rooms and hospitals could become scarce. That meant rethinking standard care, to provide the best way to treat patients under these suddenly restricted conditions. One of the new ideas: Reverse the … Read more